No Data
Amedisys Shares Could Have Downside to $74 a Share in a No-deal Scenario - Analyst
Amedisys on Pace for Largest Percent Decrease Since November 2022 -- Data Talk
Amedisys, Inc. (AMED) is currently at $91.10, down $4.91 or 5.11% --Would be lowest close since April 24, 2024, when it closed at $91.05 --On pace for largest percent decrease since Nov. 2, 2022, wh
Amedisys Falls Amid Report Divestiture Buyer in UnitedHealth Deal Is Gone
Analysts' Opinions Are Mixed on These Healthcare Stocks: Nano-X Imaging (NNOX), Argenx Se (ARGX) and Amedisys (AMED)
Cantor Fitzgerald: Reiterates Amedisys (AMED.US) rating, adjusted from neutral to neutral, with a target price of $101.00.
Cantor Fitzgerald: Reiterates Amedisys (AMED.US) rating, adjusted from neutral to neutral, with a target price of $101.00.
Cantor Fitzgerald Reiterates Neutral on Amedisys, Maintains $101 Price Target
Cantor Fitzgerald analyst Sarah James reiterates Amedisys with a Neutral and maintains $101 price target.